FDA Biologics (BLA & Biosimilars)Original article
FDA Roundtable: Strengthening the Supply Chain for Blood Manufacturing - 09/29/2026
Whole BloodBlood componentsSource PlasmaNeutral
AI Analysis
Summary
The FDA's Center for Biologics Evaluation and Research is hosting a roundtable on September 29, 2026 to discuss strengthening the supply chain for blood collection and manufacturing for transfusion and further manufacturing purposes.
Importance:2/10
Sentiment:
0.00
FDABlood supply chainRegulatoryManufacturingCBER
Read the original article
Published by FDA Biologics (BLA & Biosimilars) on September 2, 2026 4:31 PM